ReviewBMJ (Clinical research ed.)2001
Benign prostatic hyperplasia.
Review in BMJ (Clinical research ed.), 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Systematic review and meta-analysis of Transurethral Needle Ablation in symptomatic Benign Prostatic Hyperplasia.BMC urology · 2006Pooled it
- Finasteride in the treatment of clinical benign prostatic hyperplasia: a systematic review of randomised trials.BMC urology · 2002Pooled it
- Trial
- Transurethral intraprostatic Botulinum toxin-A injection: a novel treatment for BPH refractory to current medical therapy in poor surgical candidates.World journal of urology · 2013Trial
- Botulinum neurotoxin type A for the treatment of benign prostatic hyperplasia: randomized study comparing two doses.TheScientificWorldJournal · 2012Trial
- Phytochemical Profiling of the Halophyte Artemisia fukudo Makino and Its In Vitro Effects on Androgen-Related Pathways Associated With Benign Prostatic Hyperplasia and Alopecia.ChemistryOpen · 2026Article
- The relationship between the a body shape index and benign prostatic hyperplasia in middle-aged and elderly adults: a nationwide cohort study.BMC urology · 2025Article
- Verification of Qianlong Shutong Formula in the Treatment of Benign Prostatic Hyperplasia.Combinatorial chemistry & high throughput screening · 2025Article
- A MOF-Templated Double-Shelled CoNanomaterials (Basel, Switzerland) · 2024Article
- Safety profile of colocasia esculenta tuber extracts in benign prostate hyperplasia.BMC complementary medicine and therapies · 2023Article
- Critical Analysis on Characterization, Systemic Effect, and Therapeutic Potential of Beta-Sitosterol: A Plant-Derived Orphan Phytosterol.Medicines (Basel, Switzerland) · 2016Review
- Effects of D-004, a lipid extract of the fruit of the Cuban royal palm (Roystonea regia) or the lipidosterolic extract of saw palmetto (Serenoa repens) on the sexual activity in male rats: A controlled, experimental study.Current therapeutic research, clinical and experimental · 2008Article
- Plasma levels, tissue distribution, and excretion of radioactivity after single-dose administration of ((3)H)-oleic acid added to D-004, a lipid extract of the fruit of Roystonea regia, in rats.Current therapeutic research, clinical and experimental · 2006Article
- In vitro effect of D-004, a lipid extract of the fruit of the cuban royal palm (Roystonea regia), on prostate steroid 5α-reductase activity.Current therapeutic research, clinical and experimental · 2006Article
- Management of bladder, prostatic and pelvic floor disorders.Neurotoxicity research · 2006Review
- Effects of D-004, a lipid extract from Cuban royal palm fruit, on inhibiting prostatic hypertrophy induced with testosterone or dihydrotestosterone in a rat model: A randomized, controlled study.Current therapeutic research, clinical and experimental · 2004Article
- A case-based evaluation of SRD5A1, SRD5A2, AR, and ADRA1A as candidate genes for severity of BPH.The pharmacogenomics journal · 2004Article
- Global, Regional, and National Incidence and Year Lived with Disability for Benign Prostatic Hyperplasia from 1990 to 2019.American journal of men's healthArticle
- Article
- Rice bran oil ameliorates the symptoms of benign prostatic hyperplasia in male Wistar rats.Avicenna journal of phytomedicineArticle
Corrections and comments
- Erratum issued
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.